|
Press Releases |
|
|
|
Wednesday, March 23, 2022 |
|
Alset International Ltd establishes Alset Mining Pte Ltd to embark on cryptocurrency mining activities |
Singapore Exchange-listed Alset International Ltd (SGX Stock Code: 40V) ("Alset", the "Company" or together with its subsidiaries, the "Group) wishes to announce that the Company has plans to embark on cryptocurrency mining business through its subsidiary Alset Mining Pte. Ltd. ("Alset Mining"). more info >> |
|
Monday, February 21, 2022 |
|
Alset Capital Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option |
Alset Capital Acquisition Corp. (the "Company") announced on February 3, 2022 the closing of its initial public offering of 7,500,000 units at $10.00 per unit (the "Offering"). more info >> |
|
Monday, October 5, 2020 |
|
Impact BioMedical to Begin Efficacy Testing Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary Innate Immune, Inc. |
Document Security Systems, Inc. today announced its wholly owned subsidiary Impact BioMedical, Inc. ("Impact BioMedical") has formed a new wholly owned subsidiary, Innate Immune, Inc. ("Innate Immune"), to initiate efficacy testing of a pancoronavirus vaccine, a special type of vaccine designed to protect against multiple coronaviruses. more info >> |
|
Friday, September 18, 2020 |
|
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance |
Document Security Systems, Inc. (NYSE American: DSS) today announced its wholly owned subsidiary Impact BioMedical, Inc., through its subsidiary Global BioLife, Inc., completed efficacy testing of its proprietary 3F Antiviral Biofragrance at a biosafety level 3 containment facility at an independent university. more info >> |
|
Friday, July 31, 2020 |
|
Impact Biomedical initiates Quantum, a new frontier in Pharmaceutical Development |
SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly-owned subsidiary Impact Biomedical Inc. ("Impact"), announced today the initiation of Quantum, their research program designed to solve the impending pharmaceutical patent cliff threat. more info >> |
|
Wednesday, June 24, 2020 |
|
Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance |
SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. ("Impact Biomedical") announced today that they proved in vitro success of Equivir and 3F Biofragrance against COVID-19 in independent laboratory testing. more info >> |
|
Wednesday, June 17, 2020 |
|
Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal |
SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. ("Impact Biomedical") announced today that their COVID-19 research with Global Research and Discovery Group Sciences ("GRDG"), conducted in collaboration with Harvard Medical School and Vilotos Pharmaceutical, Inc. ("Vilotos"), was published in the peer-reviewed scientific journal Molecules on June 11, 2020. more info >> |
|
Monday, June 1, 2020 |
|
Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts |
SGX-listed Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary, Impact Biomedical Inc., would like to update its stakeholders on its suite of antiviral and medical technologies. more info >> |
|
Friday, April 24, 2020 |
|
Impact Biomedical's Majority Owned Next Generation Medical Technologies Valued at USD 592 Million (SGD 841 Million) by Independent Experts |
SGX-listed Singapore eDevelopment Ltd's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc., announced recently that their suite of antiviral and medical technologies, co-owned with its partners, is valued at USD 592 Million (SGD 841 Million). Impact Biomedical's effective ownership of 64.53% in the suite of technologies equates to a value of USD 382 Million (SGD 542 Million). more info >> |
|
Wednesday, March 18, 2020 |
|
Impact BioMedical's Linebacker and Equivir inhibit SARS-CoV-2, virus responsible for the COVID-19 outbreak |
Singapore Exchange-listed Singapore eDevelopment Limited has announced that its wholly-owned U.S. biomedical subsidiary, Impact BioMedical, Inc., has, through its scientific research partner, GRDG Sciences, LLC. ("GRDG"), recently conducted molecular docking studies, utilizing advanced computational models, which indicate Linebacker and Equivir successfully inhibit infection of SARS-CoV-2, the virus responsible for the COVID-19 outbreak. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Hong Kong Films @ Busan 2024 opens tomorrow
Oct 4, 2024 22:00 HKT/SGT
|
|
|
Antidote Announces $100M for Community Building and User Rewards
Oct 4, 2024 20:00: JST
|
|
|
Antidote Announces $100M for Community Building and User Rewards
Oct 4, 2024 19:00 HKT/SGT
|
|
|
CNNが人々の生活をつなぐ医療の未来を探る特別番組「Tomorrow Transformed」を放送
Oct 4, 2024 19:00: JST
|
|
|
Indonesia's Path to Society 5.0: Driving Digital Innovation at the Digital Transformation Summit
Oct 4, 2024 16:34: JST
|
|
|
Indonesia's Path to Society 5.0: Driving Digital Innovation at the Digital Transformation Summit
Oct 4, 2024 15:34 HKT/SGT
|
|
|
三菱重工、防衛省向け3,000トン型潜水艦「ちょうげい」の命名式・進水式を神戸造船所で実施
Oct 4, 2024 15:00: JST
|
|
|
Honda、「N-BOX」が2024年度上半期 新車販売台数 第1位を獲得
Oct 4, 2024 15:00: JST
|
|
|
Pluk Phak Praw Rak Mae PCL (SET: OKJ) Eyes Expansion as the 'King of Organic Salad'
Oct 4, 2024 14:00 HKT/SGT
|
|
|
富士通、「人とAIのコラボレーションによる価値創造」をテーマに「CEATEC 2024」に出展
Oct 4, 2024 10:30: JST
|
|
|
Fujitsu highlights technologies to realize its vision of AI as a trusted assistant at CEATEC 2024
Oct 4, 2024 11:03 JST
|
|
|
Four major tech fairs open in October
Oct 3, 2024 22:09 HKT/SGT
|
|
|
AVIA Announces "Vietnam in View" Conference, Highlighting Growth and Opportunities in Vietnam's Media and Entertainment Industry
Oct 3, 2024 19:30 HKT/SGT
|
|
|
周大福人寿迈向40周年 推出“匠心-传承”储蓄寿险计划 2
Oct 3, 2024 18:42 HKT/SGT
|
|
|
周大福人壽邁向40周年 推出「匠心-傳承」儲蓄壽險計劃 2
Oct 3, 2024 17:03 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|